EUVIMEDOdkrijte EUVIMED
Crossref

Diagnostic Bias in AUS Thyroid Cytology: Role of Perceived Molecular Testing

Olcay Kurtulan iD, Irem Kilic, Hanife Avcı, Güliz A Barkan iD

Diagnostic Cytopathology · 2026

DOI: 10.1002/dc.70092 ↗

At a glance

Journal article in Diagnostic Cytopathology, 2026. Written by Olcay Kurtulan and 3 co-authors. Institution: Department of Pathology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Major MEDLINE topics: Thyroid Neoplasms, Thyroid Gland, Thyroid Nodule. 29 references.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Background

Atypia of undetermined significance (AUS) represents one of the most controversial diagnostic categories in thyroid cytology, often subject to interpretive bias. This study evaluates whether perceived knowledge of a “positive molecular test” influences the cytologic interpretation of thyroid fine‐needle aspiration (FNA) specimens diagnosed as AUS.

Methods

Twenty thyroid FNA cases diagnosed as AUS with benign histologic follow‐up following thyroidectomy were selected: eight with nuclear atypia (AUS‐N), eight with architectural atypia (AUS‐A), and four with oncocytic features. Representative slides (Papanicolaou and Diff Quik stained smears) were chosen and participants were instructed to evaluate the cases based on morphologic evaluation. Randomly selected 10 cases in two groups were presented to 10 participants as having “positive ThyroSeq test” or “no molecular testing information.” No molecular testing was performed in reality, as the aim was to measure the effects of “perceived positive testing.” Results Analysis of 200 responses showed AUS remained the predominant diagnosis (64%) in both groups. When informed of a presumed positive molecular test, participants were more likely to assign a neoplastic or malignant diagnosis (24% vs. 12%, p = 0.023). This trend was most pronounced in AUS‐N cases (11 vs. 1 reclassified as suspicious/malignant). For AUS‐A cases, more were reclassified as follicular neoplasm under presumed molecular positivity (12 vs. 8). Overall interobserver agreement was poor (Fleiss' kappa = 0.046).

Conclusion

Awareness of a presumed positive molecular test result increases the likelihood of pathologists reclassifying AUS cases as suspicious or malignant. Recognizing and mitigating such cognitive biases is critical for maintaining diagnostic objectivity and ensuring accurate, evidence‐based cytologic evaluation.

Subjects

MeSH terms (MEDLINE)

Thyroid NeoplasmsThyroid GlandThyroid NoduleHumansBiopsy, Fine-NeedleFemaleCytodiagnosisMolecular Diagnostic Techniques

Author keywords

FNAatypia of undetermined significancebiasmolecular testingthyroid

Authors and institutions

  • Department of Pathology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Department of Pathology and Laboratory Medicine, Loyola University Healthcare System, Maywood, Illinois, USA.
  • Department of Biostatistics, Hacettepe University Faculty of Medicine, Ankara, Turkey.

ORCID profiles: Olcay Kurtulan, Güliz A Barkan

Cite

APA

Kurtulan, O., Kilic, I., Avcı, H., & Barkan, G. A. (2026). Diagnostic Bias in AUS Thyroid Cytology: Role of Perceived Molecular Testing. Diagnostic Cytopathology. https://doi.org/10.1002/dc.70092

Vancouver

Kurtulan O, Kilic I, Avcı H, Barkan GA. Diagnostic Bias in AUS Thyroid Cytology: Role of Perceived Molecular Testing. Diagnostic Cytopathology. 2026. doi:10.1002/dc.70092

BibTeX
@article{Kurtulan2026,
  author = {Kurtulan, Olcay and Kilic, Irem and Avcı, Hanife and Barkan, Güliz A},
  title = {Diagnostic Bias in AUS Thyroid Cytology: Role of Perceived Molecular Testing},
  journal = {Diagnostic Cytopathology},
  year = {2026},
  doi = {10.1002/dc.70092}
}
Start for free →